Trudy Buckingham, MSPH
Trudy is the Executive Director of Patient-Focused Implementation Science at Gilead Sciences, a biotechnology company with sights set on preventing, treating, and curing life-threatening diseases through the next generation of life-changing medicines and global health partnerships. Trudy is an experienced and visionary healthcare leader specializing in mission-driven innovation, focusing on improving patient experiences, especially as it relates to digital health initiatives. She has a proven track record championing health equity and facilitating informed decision-making and she is passionate about transforming healthcare through collaborative and bespoke partnerships in technology, science, education, and digital health. She is dedicated to accelerating evidence-based solutions, integrating advances into practice, and advocating for under-served populations navigating and engaging healthcare complexities. Prior to her role at Gilead, Trudy worked in various senior leadership and director roles at pharmaceutical companies such as GSK, AstraZeneca, and Elan. Trudy also holds an MSPH in Health Policy and Pharmacoeconomics from the University of North Carolina at Chapel Hill.